CXCR2 and prostate adenocarcinoma: Despite IL-8 and CXCR2 having been found to be highly expressed in NE cells of PCa [20], the mechanisms through which upregulation of IL-8/CXCR2 signaling promotes NED and malignant progression of prostate adenocarcinomas post-ADT are not clear.